This is the second part of my investigative report. If you valued reading Part 1, consider becoming a paid subscriber or make a one-off contribution.
I turned to the lead author of the Speicher et al. paper, David Speicher Ph.D., molecular virologist and writer of
for his view on the UK’s MHRA recent disclosure of …